LYMPHATIC MALFORMATION
Clinical trials for LYMPHATIC MALFORMATION explained in plain language.
Never miss a new study
Get alerted when new LYMPHATIC MALFORMATION trials appear
Sign up with your email to follow new studies for LYMPHATIC MALFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a common drug shrink rare facial growths in kids?
Disease control Recruiting nowThis study tests if the drug rapamycin can reduce the size of large, hard-to-treat lymphatic malformations in the face and neck of children. About 28 children aged 0 to 18 will take rapamycin by mouth for 6 months. The goal is to see if the malformations shrink by at least one-fi…
Matched conditions: LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 01, 2026 19:27 UTC
-
New injection offers hope for children with painful cysts
Disease control Recruiting nowThis study tests an experimental drug called TARA-002 for children aged 6 months to 18 years who have lymphatic malformations (fluid-filled cysts). The drug is injected directly into the cysts to shrink them. Up to 38 children will receive up to 4 injections over about 6 months. …
Matched conditions: LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs (alpelisib and mirdametinib) in 50 people aged 2 and older with vascular malformations—abnormal blood or lymph vessels. The drugs aim to shrink or improve these growths by blocking specific genetic signals. Participants take the drug for 48 wee…
Matched conditions: LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Weekly pill may tame painful vascular birthmarks with fewer side effects
Disease control Recruiting nowThis study tests whether taking sirolimus once a week can safely shrink abnormal veins and lymph vessels (called malformations) that cause pain and swelling. About 24 people aged 2 and older will take the drug for 6 months. The goal is to see if weekly dosing works as well as dai…
Matched conditions: LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC